Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Osteosarcoma × Erlotinib Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 2 Lung Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

Specimen Handling 6 Cyclophosphamide 6 Temozolomide 5 Magnetic Resonance Spectroscopy 5 Biopsy 5 fludarabine 4 X-Rays 4 Phantoms, Imaging 4 Doxorubicin 4 dinutuximab 3 cabozantinib 3 Vincristine 3 Methotrexate 3 Irinotecan 3 Ifosfamide 3 Gemcitabine 3 Cisplatin 3 olaparib 2 mifamurtide 2 ivosidenib 2 irinotecan sucrosofate 2 ensartinib 2 atezolizumab 2 Zoledronic Acid 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Nuclear Medicine Department, Hospital 2 Etoposide 2 Eflornithine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡